NOTCH1 and non-small cell lung carcinoma: First, the experiments only proved that NY-2 was effective and safe for the treatment of NSCLC, but its mechanism has not been discussed in depth, only western blot experiments were conducted to verify its action on Notch1 and Intergrinβ1 signaling pathways.